Scarica l'app Stockscreener
1.525
5.28%
-0.085
Precedente Chiudi:
$1.61
Aprire:
$1.64
Volume 24 ore:
872.23K
Relative Volume:
0.66
Capitalizzazione di mercato:
$247.71M
Reddito:
$400.57M
Utile/perdita netta:
$9.21M
Rapporto P/E:
38.12
EPS:
0.04
Flusso di cassa netto:
$146.36M
1 W Prestazione:
-13.84%
1M Prestazione:
+17.31%
6M Prestazione:
+103.33%
1 anno Prestazione:
-66.11%
Intervallo 1D:
$1.5135
$1.71
Intervallo di 1 settimana:
$1.41
$1.94
Portata 52W:
$0.5271
$5.1288
Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile
Nome
Ironwood Pharmaceuticals Inc
Settore
Telefono
617-621-7722
Indirizzo
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Confronta IRWD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
1.525 | 240.40M | 400.57M | 9.21M | 146.36M | 0.04 |
|
ZTS
Zoetis Inc
|
143.91 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.91 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.2001 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.78 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
430.14 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-15 | Downgrade | Jefferies | Buy → Hold |
| 2025-04-15 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | Downgrade | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | Iniziato | Leerink Partners | Market Perform |
| 2024-08-08 | Downgrade | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | Iniziato | Craig Hallum | Buy |
| 2023-12-14 | Iniziato | Wells Fargo | Overweight |
| 2023-11-09 | Iniziato | Jefferies | Buy |
| 2023-09-28 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-02 | Iniziato | CapitalOne | Overweight |
| 2022-04-22 | Iniziato | Piper Sandler | Overweight |
| 2020-09-30 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | Iniziato | Northland Capital | Outperform |
| 2019-07-10 | Ripresa | Credit Suisse | Neutral |
| 2019-03-27 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | Aggiornamento | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2018-11-07 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-07-23 | Iniziato | H.C. Wainwright | Sell |
| 2018-05-09 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | Downgrade | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | Downgrade | Mizuho | Buy → Neutral |
| 2017-07-21 | Downgrade | JP Morgan | Overweight → Neutral |
| 2017-05-03 | Iniziato | Wells Fargo | Outperform |
| 2017-04-07 | Reiterato | Mizuho | Buy |
| 2017-02-22 | Reiterato | Barclays | Equal Weight |
| 2016-11-04 | Reiterato | Mizuho | Buy |
| 2016-10-24 | Reiterato | Wedbush | Neutral |
| 2016-10-10 | Reiterato | Mizuho | Buy |
| 2016-09-27 | Reiterato | WallachBeth | Hold |
Mostra tutto
Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie
News impact scoring models applied to Ironwood Pharmaceuticals Inc.Market Movers & Fast Entry Momentum Trade Alerts - newser.com
What is the fair value of Ironwood Pharmaceuticals Inc. stock nowTrade Analysis Summary & Stepwise Trade Signal Guides - newser.com
Applying Wyckoff theory to Ironwood Pharmaceuticals Inc. stock2025 Trading Recap & Reliable Volume Spike Trade Alerts - newser.com
Is this a good reentry point in Ironwood Pharmaceuticals Inc.Short Setup & Advanced Technical Analysis Signals - newser.com
Quantitative breakdown of Ironwood Pharmaceuticals Inc. recent move2025 Stock Rankings & Real-Time Chart Pattern Alerts - newser.com
Analyzing Ironwood Pharmaceuticals Inc. with risk reward ratio chartsM&A Rumor & Community Trade Idea Sharing Platform - newser.com
Zacks Industry Outlook Highlights Akebia Therapeutics, Ironwood Pharmaceuticals, Pyxis Oncology, Cardiol Therapeutics and Plus Therapeutics - Yahoo Finance
What does recent volatility data suggest for Ironwood Pharmaceuticals Inc.Weekly Loss Report & Precise Swing Trade Entry Alerts - newser.com
5 Small Drug Stocks to Buy as the Industry Shows Some Recovery - Yahoo Finance
Top chart patterns to watch in Ironwood Pharmaceuticals Inc.Weekly Gains Summary & Breakout Confirmation Trade Signals - newser.com
Why Ironwood Pharmaceuticals (IRWD) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Inspire Investing LLC Raises Stock Holdings in Ironwood Pharmaceuticals, Inc. $IRWD - MarketBeat
Can technical indicators confirm Ironwood Pharmaceuticals Inc.’s reversal - newser.com
Price momentum metrics for Ironwood Pharmaceuticals Inc. explainedJobs Report & Fast Entry Momentum Trade Alerts - newser.com
Wealth Enhancement Advisory Services LLC Has $96,000 Stake in Ironwood Pharmaceuticals, Inc. $IRWD - Defense World
Ironwood Pharma Board Member Resigns for New Role - TipRanks
Ironwood Pharmaceuticals director Andrew Dreyfus to resign effective November 1 - Investing.com
What drives Ironwood Pharmaceuticals Inc stock priceEarnings Surprise Analysis & Start Learning With Our Courses - earlytimes.in
Weiss Ratings Reiterates Sell (E+) Rating for Ironwood Pharmaceuticals (NASDAQ:IRWD) - MarketBeat
Published on: 2025-10-09 01:18:56 - newser.com
Ironwood Pharmaceuticals Inc. stock daily chart insights2025 Technical Patterns & AI Driven Price Predictions - newser.com
Ironwood Pharmaceuticals (NASDAQ:IRWD) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
How risky is Ironwood Pharmaceuticals Inc. stock nowJuly 2025 Drop Watch & Community Shared Stock Ideas - newser.com
Reversal indicators forming on Ironwood Pharmaceuticals Inc. stockWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
What MACD and RSI say about Ironwood Pharmaceuticals Inc.2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com
Can Ironwood Pharmaceuticals Inc. (I76) stock retain market dominanceFed Meeting & Capital Efficient Trading Techniques - newser.com
Can Ironwood Pharmaceuticals Inc. hit a new high this monthJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Visualizing Ironwood Pharmaceuticals Inc. stock with heatmapsMarket Growth Report & Daily Market Momentum Tracking - newser.com
Strategies to average down on Ironwood Pharmaceuticals Inc.2025 Key Lessons & Technical Pattern Based Signals - newser.com
Will Ironwood Pharmaceuticals Inc. price bounce be sustainableShare Buyback & Free Weekly Watchlist of Top Performers - newser.com
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Can momentum traders help lift Ironwood Pharmaceuticals Inc.July 2025 Rallies & High Yield Stock Recommendations - newser.com
Published on: 2025-10-03 03:28:42 - newser.com
Published on: 2025-10-01 06:27:53 - newser.com
IRWD's Q4 Earnings and Revenues Fall Shy of Estimates, Stock Down - MSN
Ironwood focuses on apraglutide amid workforce cuts - MSN
Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ironwood Pharmaceuticals Inc Azioni (IRWD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| John Minardo | Chief Legal Officer |
Aug 11 '25 |
Sale |
0.84 |
7,754 |
6,513 |
400,378 |
| Martini Gregory S. | Chief Financial Officer |
Aug 11 '25 |
Sale |
0.84 |
1,265 |
1,063 |
182,545 |
| Silver Ronald | Principal Accounting Officer |
Aug 11 '25 |
Sale |
0.84 |
2,846 |
2,391 |
276,809 |
0.56%
0.75%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):